LAS VEGAS: Dementia experts are cautiously optimistic a new drug could slow the progression of dementia by one-third.
New findings into a drug called solanezumab have been released.
Neurologist Dr Eric Siemers — who works with the drug’s manufacturer Eli Lilly — said the medication could help keep brain cells alive and the disease from progressing.
“Based on the currently available data, the rate of decline is slowed by 34 per cent,” Dr Siemers said.
The drug had been tested in Alzheimer’s patients with limited success.
But researchers went back and analysed the results for 1,000 people with mild dementia.
Eli Lilly said patients with mild Alzheimer’s disease who took the experimental drug early in the course of their disease preserved more of their cognitive and functional ability…